{"id":14447,"date":"2023-07-12T15:09:17","date_gmt":"2023-07-12T12:09:17","guid":{"rendered":"https:\/\/stage.www.cobalt.legal\/?p=14447"},"modified":"2023-07-12T15:09:56","modified_gmt":"2023-07-12T12:09:56","slug":"advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics","status":"publish","type":"post","link":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/","title":{"rendered":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics"},"content":{"rendered":"

Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics.<\/p>\n

Blueprint Genetics on rahvusvaheliselt edukas p\u00e4rilike haiguste diagnoosimiseks vajalike geneetiliste testimiste teostaja. Finantseerimise tulemusena kaasati 14 miljonit eurot. Lisaks uutele investoritele osalesid finantseerimises ka olemasolevad investorid Inventure ja Pontos Group.<\/p>\n

Advokaadib\u00fcroo COBALT poolt n\u00f5ustasid kliente partner Kristel Raidla-Talur ja advokaadid Greete-Kristiine Kuru, Jesse Kivisaari, Aleksander Tsuiman ja Liina Saaremets.<\/p>\n

COBALT advokaadid n\u00f5ustasid kliente terve tehingu v\u00e4ltel, sh juriidilise auditi l\u00e4biviimisel ja tehingudokumentide l\u00e4bir\u00e4\u00e4kimistel.<\/p>\n

Tutvu ka meediakajastusega siin<\/a> ja siin<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics. Blueprint Genetics on rahvusvaheliselt edukas p\u00e4rilike haiguste diagnoosimiseks vajalike geneetiliste testimiste teostaja. Finantseerimise tulemusena kaasati 14 miljonit eurot. Lisaks uutele investoritele osalesid finantseerimises ka..<\/p>\n","protected":false},"author":5,"featured_media":14450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[28],"country":[84],"class_list":["post-14447","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-et","country-estonia-et"],"acf":[],"yoast_head":"\nAdvokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics | COBALT<\/title>\n<meta name=\"description\" content=\"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics | COBALT\" \/>\n<meta property=\"og:description\" content=\"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/\" \/>\n<meta property=\"og:site_name\" content=\"COBALT\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CobaltLegal\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-12T12:09:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-12T12:09:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/dna-163466_960_720.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"saturs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"saturs\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/\"},\"author\":{\"name\":\"saturs\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#\\\/schema\\\/person\\\/8b9371cd6186321c5b42e891663a4ec0\"},\"headline\":\"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics\",\"datePublished\":\"2023-07-12T12:09:17+00:00\",\"dateModified\":\"2023-07-12T12:09:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/\"},\"wordCount\":114,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/dna-163466_960_720.jpg\",\"articleSection\":[\"Uncategorized @et\"],\"inLanguage\":\"et-EE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/\",\"name\":\"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics | COBALT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/dna-163466_960_720.jpg\",\"datePublished\":\"2023-07-12T12:09:17+00:00\",\"dateModified\":\"2023-07-12T12:09:56+00:00\",\"description\":\"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics. News. Naujienos. Jaunumi. Uudised.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/#breadcrumb\"},\"inLanguage\":\"et-EE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et-EE\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/dna-163466_960_720.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/dna-163466_960_720.jpg\",\"width\":960,\"height\":540},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/news-cases\\\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#website\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/\",\"name\":\"COBALT\",\"description\":\"Top-tier law services in Estonia, Latvia and Lithuania\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et-EE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#organization\",\"name\":\"COBALT\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et-EE\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"width\":400,\"height\":116,\"caption\":\"COBALT\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CobaltLegal\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/#\\\/schema\\\/person\\\/8b9371cd6186321c5b42e891663a4ec0\",\"name\":\"saturs\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/et\\\/author\\\/saturs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics | COBALT","description":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics. News. Naujienos. Jaunumi. Uudised.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/","og_locale":"et_EE","og_type":"article","og_title":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics | COBALT","og_description":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics. News. Naujienos. Jaunumi. Uudised.","og_url":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/","og_site_name":"COBALT","article_publisher":"https:\/\/www.facebook.com\/CobaltLegal\/","article_published_time":"2023-07-12T12:09:17+00:00","article_modified_time":"2023-07-12T12:09:56+00:00","og_image":[{"width":960,"height":540,"url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/dna-163466_960_720.jpg","type":"image\/jpeg"}],"author":"saturs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"saturs"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/#article","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/"},"author":{"name":"saturs","@id":"https:\/\/www.cobalt.legal\/et\/#\/schema\/person\/8b9371cd6186321c5b42e891663a4ec0"},"headline":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics","datePublished":"2023-07-12T12:09:17+00:00","dateModified":"2023-07-12T12:09:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/"},"wordCount":114,"publisher":{"@id":"https:\/\/www.cobalt.legal\/et\/#organization"},"image":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/dna-163466_960_720.jpg","articleSection":["Uncategorized @et"],"inLanguage":"et-EE"},{"@type":"WebPage","@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/","url":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/","name":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics | COBALT","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/#primaryimage"},"image":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/dna-163466_960_720.jpg","datePublished":"2023-07-12T12:09:17+00:00","dateModified":"2023-07-12T12:09:56+00:00","description":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics. News. Naujienos. Jaunumi. Uudised.","breadcrumb":{"@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/#breadcrumb"},"inLanguage":"et-EE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/"]}]},{"@type":"ImageObject","inLanguage":"et-EE","@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/#primaryimage","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/dna-163466_960_720.jpg","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/07\/dna-163466_960_720.jpg","width":960,"height":540},{"@type":"BreadcrumbList","@id":"https:\/\/www.cobalt.legal\/et\/news-cases\/advokaadiburoo-cobalt-noustas-riskifonde-creathor-venture-ja-mtip-medtech-innovation-partners-investeeringus-soome-startupi-blueprint-genetics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cobalt.legal\/et\/"},{"@type":"ListItem","position":2,"name":"Advokaadib\u00fcroo COBALT n\u00f5ustas riskifonde Creathor Venture ja MTIP (MedTech Innovation Partners) investeeringus Soome startup\u00b4i Blueprint Genetics"}]},{"@type":"WebSite","@id":"https:\/\/www.cobalt.legal\/et\/#website","url":"https:\/\/www.cobalt.legal\/et\/","name":"COBALT","description":"Top-tier law services in Estonia, Latvia and Lithuania","publisher":{"@id":"https:\/\/www.cobalt.legal\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cobalt.legal\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et-EE"},{"@type":"Organization","@id":"https:\/\/www.cobalt.legal\/et\/#organization","name":"COBALT","url":"https:\/\/www.cobalt.legal\/et\/","logo":{"@type":"ImageObject","inLanguage":"et-EE","@id":"https:\/\/www.cobalt.legal\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","width":400,"height":116,"caption":"COBALT"},"image":{"@id":"https:\/\/www.cobalt.legal\/et\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CobaltLegal\/"]},{"@type":"Person","@id":"https:\/\/www.cobalt.legal\/et\/#\/schema\/person\/8b9371cd6186321c5b42e891663a4ec0","name":"saturs","url":"https:\/\/www.cobalt.legal\/et\/author\/saturs\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/posts\/14447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/comments?post=14447"}],"version-history":[{"count":1,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/posts\/14447\/revisions"}],"predecessor-version":[{"id":14448,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/posts\/14447\/revisions\/14448"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/media\/14450"}],"wp:attachment":[{"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/media?parent=14447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/categories?post=14447"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.cobalt.legal\/et\/wp-json\/wp\/v2\/country?post=14447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}